| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | WW domain binding | 1.56e-04 | 25 | 15 | 2 | GO:0050699 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 7.20e-03 | 172 | 15 | 2 | GO:0008757 | |
| GeneOntologyBiologicalProcess | positive regulation of mitophagy | 5.89e-05 | 16 | 15 | 2 | GO:1901526 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy of mitochondrion | 8.38e-05 | 19 | 15 | 2 | GO:1903599 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 3.08e-04 | 187 | 15 | 3 | GO:0007034 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 3.42e-04 | 38 | 15 | 2 | GO:1901524 | |
| GeneOntologyBiologicalProcess | regulation of autophagy of mitochondrion | 4.80e-04 | 45 | 15 | 2 | GO:1903146 | |
| HumanPheno | Pes cavus | 8.05e-04 | 304 | 4 | 3 | HP:0001761 | |
| HumanPheno | Progressive neurologic deterioration | 8.06e-04 | 60 | 4 | 2 | HP:0002344 | |
| HumanPheno | Axial hypotonia | 1.06e-03 | 334 | 4 | 3 | HP:0008936 | |
| HumanPheno | Abnormal metabolic brain imaging by MRS | 1.10e-03 | 70 | 4 | 2 | HP:0012705 | |
| HumanPheno | Truncal ataxia | 1.33e-03 | 77 | 4 | 2 | HP:0002078 | |
| HumanPheno | Myoclonus | 1.45e-03 | 371 | 4 | 3 | HP:0001336 | |
| HumanPheno | Limb ataxia | 1.89e-03 | 92 | 4 | 2 | HP:0002070 | |
| HumanPheno | Ataxia | 1.96e-03 | 1073 | 4 | 4 | HP:0001251 | |
| HumanPheno | Cachexia | 2.23e-03 | 100 | 4 | 2 | HP:0004326 | |
| HumanPheno | Sensorimotor neuropathy | 2.41e-03 | 104 | 4 | 2 | HP:0007141 | |
| MousePheno | lipofuscinosis | 9.60e-05 | 21 | 10 | 2 | MP:0008842 | |
| MousePheno | gliosis | 2.03e-04 | 171 | 10 | 3 | MP:0002183 | |
| MousePheno | abnormal neuron physiology | 5.88e-04 | 604 | 10 | 4 | MP:0004811 | |
| MousePheno | ataxia | 7.40e-04 | 266 | 10 | 3 | MP:0001393 | |
| MousePheno | abnormal cerebellar foliation | 7.45e-04 | 58 | 10 | 2 | MP:0000857 | |
| MousePheno | abnormal CNS glial cell morphology | 7.90e-04 | 272 | 10 | 3 | MP:0000952 | |
| MousePheno | abnormal motor learning | 7.97e-04 | 60 | 10 | 2 | MP:0002804 | |
| MousePheno | abnormal cerebellum lobule morphology | 1.05e-03 | 69 | 10 | 2 | MP:0009964 | |
| MousePheno | weight loss | 1.18e-03 | 312 | 10 | 3 | MP:0001263 | |
| MousePheno | abnormal locomotor coordination | 1.18e-03 | 726 | 10 | 4 | MP:0003312 | |
| MousePheno | abnormal apoptosis | 1.40e-03 | 1353 | 10 | 5 | MP:0001648 | |
| MousePheno | abnormal programmed cell death | 1.43e-03 | 1360 | 10 | 5 | MP:0014355 | |
| MousePheno | abnormal glial cell morphology | 1.57e-03 | 345 | 10 | 3 | MP:0003634 | |
| MousePheno | abnormal microglial cell morphology | 1.67e-03 | 87 | 10 | 2 | MP:0000136 | |
| MousePheno | decreased locomotor activity | 1.93e-03 | 829 | 10 | 4 | MP:0001402 | |
| MousePheno | abnormal spatial working memory | 1.94e-03 | 94 | 10 | 2 | MP:0008428 | |
| MousePheno | abnormal cerebellum development | 2.03e-03 | 96 | 10 | 2 | MP:0000854 | |
| MousePheno | muscle weakness | 2.11e-03 | 98 | 10 | 2 | MP:0000747 | |
| MousePheno | astrocytosis | 2.33e-03 | 103 | 10 | 2 | MP:0003354 | |
| MousePheno | abnormal motor coordination/balance | 2.34e-03 | 873 | 10 | 4 | MP:0001516 | |
| MousePheno | decreased brain weight | 2.46e-03 | 106 | 10 | 2 | MP:0002175 | |
| MousePheno | increased astrocyte number | 2.51e-03 | 107 | 10 | 2 | MP:0012065 | |
| MousePheno | abnormal astrocyte number | 2.75e-03 | 112 | 10 | 2 | MP:0012064 | |
| MousePheno | abnormal metencephalon morphology | 2.76e-03 | 420 | 10 | 3 | MP:0000847 | |
| MousePheno | small cerebellum | 3.09e-03 | 119 | 10 | 2 | MP:0000852 | |
| MousePheno | cachexia | 3.20e-03 | 121 | 10 | 2 | MP:0005150 | |
| Domain | DUF2370 | 6.02e-07 | 2 | 15 | 2 | PF10176 | |
| Domain | NEDD4/Bsd2 | 6.02e-07 | 2 | 15 | 2 | IPR019325 | |
| Pubmed | Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins. | 5.21e-07 | 3 | 15 | 2 | 19343052 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 26363003 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 27088444 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 18776082 | ||
| Pubmed | 2.60e-06 | 6 | 15 | 2 | 11748237 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 20534535 | ||
| Pubmed | 4.85e-06 | 8 | 15 | 2 | 30893602 | ||
| Pubmed | 1.03e-05 | 733 | 15 | 5 | 34672954 | ||
| Pubmed | 3.63e-05 | 952 | 15 | 5 | 38569033 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 3.93e-05 | 468 | 15 | 4 | 31056421 | |
| Pubmed | NDFIP allows NEDD4/NEDD4L-induced AQP2 ubiquitination and degradation. | 6.06e-05 | 27 | 15 | 2 | 28931009 | |
| Pubmed | Regulation of meiotic telomere dynamics through membrane fluidity promoted by AdipoR2-ELOVL2. | 7.00e-05 | 29 | 15 | 2 | 38485951 | |
| Pubmed | MARCH8Â Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and Mediates Viral Envelopment. | 1.34e-04 | 40 | 15 | 2 | 30759391 | |
| Interaction | BDKRB1 interactions | 1.97e-06 | 34 | 15 | 3 | int:BDKRB1 | |
| Interaction | PTGFR interactions | 1.30e-04 | 23 | 15 | 2 | int:PTGFR | |
| Interaction | HSD3B7 interactions | 1.53e-04 | 386 | 15 | 4 | int:HSD3B7 | |
| Interaction | OTULINL interactions | 1.84e-04 | 405 | 15 | 4 | int:OTULINL | |
| Interaction | KCNK18 interactions | 2.08e-04 | 29 | 15 | 2 | int:KCNK18 | |
| Interaction | SLC11A2 interactions | 3.58e-04 | 38 | 15 | 2 | int:SLC11A2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 2.03e-02 | 681 | 15 | 2 | chr1p36 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma|TCGA-Testes / Sample_Type by Project: Shred V9 | 9.69e-04 | 139 | 15 | 2 | 6b58d01ce9d9ac23434333f9faf1bb0eef14ba90 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 148 | 15 | 2 | 941bad657064b3d37cae8b66df99c1aa1098c088 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 148 | 15 | 2 | f58804d24fe524b42b5090c8658050ea4b14793e | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-dnT|Leuk-UTI / Disease, Lineage and Cell Type | 1.11e-03 | 149 | 15 | 2 | 53f145cf7089d948d41aa3c443e983e011826836 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.22e-03 | 156 | 15 | 2 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-03 | 159 | 15 | 2 | c9e093d7c1dca83f6546adaf3d874929e2cea612 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-03 | 162 | 15 | 2 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.33e-03 | 163 | 15 | 2 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-03 | 165 | 15 | 2 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-03 | 167 | 15 | 2 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 168 | 15 | 2 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-03 | 170 | 15 | 2 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-03 | 171 | 15 | 2 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | ILEUM-inflamed-(4)_Mast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.48e-03 | 172 | 15 | 2 | be82f749f4b1049ae8832facc052082cf5463c11 | |
| ToppCell | ILEUM-inflamed-(4)_Mast_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.48e-03 | 172 | 15 | 2 | 7185b28282412f3a464b2a8ad5605475a1a31358 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-03 | 174 | 15 | 2 | 64d13a7a9757e85f4f4af876c687dd18a7efa01a | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.55e-03 | 176 | 15 | 2 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-03 | 177 | 15 | 2 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-03 | 177 | 15 | 2 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-03 | 177 | 15 | 2 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-03 | 177 | 15 | 2 | 9e65b39fd797b6ce204b6480415810d1923acee5 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.69e-03 | 184 | 15 | 2 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.69e-03 | 184 | 15 | 2 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.69e-03 | 184 | 15 | 2 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.70e-03 | 185 | 15 | 2 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-03 | 185 | 15 | 2 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-03 | 186 | 15 | 2 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | 367C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-03 | 187 | 15 | 2 | 7d416693cb719df4197a11acc6b4e19171352515 | |
| ToppCell | 367C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-03 | 187 | 15 | 2 | b1341d272d9fc07c6f7590d6d398d7a5cf42240b | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.76e-03 | 188 | 15 | 2 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.80e-03 | 190 | 15 | 2 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.80e-03 | 190 | 15 | 2 | 0523f1039b39a45a23f2f4444e5b47ed581fc4bb | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_2|hematopoetic_progenitors / Lineage and Cell class | 1.82e-03 | 191 | 15 | 2 | 3b061dbc10918be7cbbd4453311d2c1ebf18c6b2 | |
| ToppCell | 390C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-03 | 192 | 15 | 2 | 15c1a0a0d07106118427135f166a1da710bf621a | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-03 | 192 | 15 | 2 | 758ca0dacf313787effda36e6d1adb809e5b3a4e | |
| ToppCell | 390C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-03 | 192 | 15 | 2 | 201d430af1e4fee7bc03baf0aca17db26f6f439a | |
| ToppCell | 3'_v3-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 1.87e-03 | 194 | 15 | 2 | 7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd | |
| ToppCell | 3'_v3-Lung-Mast|Lung / Manually curated celltypes from each tissue | 1.87e-03 | 194 | 15 | 2 | 5e6eb81ddc9d5e22c1297734689f476d5a05bff6 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.87e-03 | 194 | 15 | 2 | d8f367beab16a3186821e42311947b6c9e99978c | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.87e-03 | 194 | 15 | 2 | 5da8873cddff582e5693b32fd3aaebc102f65fc0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 1.87e-03 | 194 | 15 | 2 | e46963d5f156526342ebc0fb9e767d266e812c42 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.89e-03 | 195 | 15 | 2 | fbedb9978ded857fd35c2a8664f7579f42edaa36 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.89e-03 | 195 | 15 | 2 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.89e-03 | 195 | 15 | 2 | 8679a122fe796b1eddef82460e985b3fd3b3a2a5 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-03 | 195 | 15 | 2 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-03 | 196 | 15 | 2 | e08f90f7a923c2846cac859519b8dc7c0ac7cd03 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-03 | 196 | 15 | 2 | 0ebf7e5a9281ec1f33dccd1f8895afd513591b91 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-03 | 196 | 15 | 2 | 03710e2a843279124a45a271bffb132835e6081c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-03 | 196 | 15 | 2 | bd482b7df2993d87c0997a40c4cbd34ba07910cb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-03 | 197 | 15 | 2 | 7619924615a43011b4a86efbe6e7e5445f96722b | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.93e-03 | 197 | 15 | 2 | 5e4a004052b8560223673a339d4a0d729e533def | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.93e-03 | 197 | 15 | 2 | 61f909737c5f630beffdd326c6844215643dbdde | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.93e-03 | 197 | 15 | 2 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-RBC|COVID-19_Mild / Disease, condition lineage and cell class | 1.93e-03 | 197 | 15 | 2 | 3bae601e5d9689ea57e923814af8cdcae690becc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-03 | 198 | 15 | 2 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-03 | 198 | 15 | 2 | 2e6630eab77b12a6059682ab5ba465f38e469102 | |
| ToppCell | Biopsy_Other_PF-Immune-Mast_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.95e-03 | 198 | 15 | 2 | 9f015553598d4c6774b2f9759e8c0f0f93e51c67 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.95e-03 | 198 | 15 | 2 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-03 | 198 | 15 | 2 | a1247a5efd92f95c6227c0e71dc8a0427eb54b7f | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-03 | 199 | 15 | 2 | 01d101b0fd5326947a9e5dddae6c2f93ab6e0a4d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.97e-03 | 199 | 15 | 2 | a24a319d3ba8f4759f742af27610b4d62e359a2d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-03 | 199 | 15 | 2 | 0a657475b92aa3a713da62da364525249fdc3886 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.97e-03 | 199 | 15 | 2 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-dn_T|Leuk-UTI / Disease, condition lineage and cell class | 1.97e-03 | 199 | 15 | 2 | aa4d8ce8994e5032a33d5cc68c482882147cdc3b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-03 | 199 | 15 | 2 | a8f4bd0e65f36b29535864fae4347369d5c864d2 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-03 | 199 | 15 | 2 | eacea42e973f073b410f54c0a1b3a7f2dc2b5a29 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-03 | 199 | 15 | 2 | 5a1557fe35aa48080d4967e8724bf27f9585a5fb | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-03 | 199 | 15 | 2 | 6d439c0c5e6b72fcb8d4dc72e7445eb6a01fe095 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-03 | 200 | 15 | 2 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-03 | 200 | 15 | 2 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.99e-03 | 200 | 15 | 2 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-03 | 200 | 15 | 2 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 1.99e-03 | 200 | 15 | 2 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-03 | 200 | 15 | 2 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 1.99e-03 | 200 | 15 | 2 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 1.99e-03 | 200 | 15 | 2 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 1.99e-03 | 200 | 15 | 2 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-03 | 200 | 15 | 2 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 6.48e-06 | 194 | 15 | 4 | 2427_DN | |
| Disease | neutrophil count, eosinophil count | 3.84e-03 | 213 | 13 | 2 | EFO_0004833, EFO_0004842 | |
| Disease | neutrophil count, basophil count | 4.24e-03 | 224 | 13 | 2 | EFO_0004833, EFO_0005090 | |
| Disease | granulocyte count | 5.41e-03 | 254 | 13 | 2 | EFO_0007987 | |
| Disease | breast carcinoma | 9.06e-03 | 1019 | 13 | 3 | EFO_0000305 | |
| Disease | inflammatory bowel disease | 1.61e-02 | 449 | 13 | 2 | EFO_0003767 | |
| Disease | basophil count | 1.85e-02 | 483 | 13 | 2 | EFO_0005090 | |
| Disease | IGF-1 measurement | 1.89e-02 | 488 | 13 | 2 | EFO_0004627 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHVWNYGWAFYMAWL | 226 | Q2KHT4 | |
| YAGIFRFWFWHYGNW | 131 | A8MX76 | |
| KDPYYGADWGIGWWT | 206 | Q7Z3D4 | |
| IYGSPWQPWFYGWGF | 206 | O15442 | |
| WQPWFYGWGFNLPRG | 211 | O15442 | |
| TGYFNGQYWLWWIFL | 286 | Q9NV92 | |
| PGYFDGQYWLWWVFL | 171 | Q9BT67 | |
| AWFRHPSYVGWFYWS | 206 | O60725 | |
| SFGFSWFWFRLYWFP | 246 | P27544 | |
| WSFPGWLGKGFDWPY | 151 | P54803 | |
| NGEYAWYYEGRNGWW | 101 | Q9NTX7 | |
| YVYPWWGEAMGWAFA | 551 | P48029 | |
| PTFIGWFFTWDPYKW | 696 | O15195 | |
| ASGVFWWLGIGWYQF | 256 | O94901 | |
| YWNEYGGGLLWQSWQ | 201 | Q96RS0 | |
| QYLQSWFPGWGGWYG | 431 | Q5THJ4 |